EVY LUNDGREN-ÅKERLUND

CEO
Xintela

Evy holds a Ph.D and is Associate Professor in medical sciences and also the founder of Xintela – a biomedical company working in the fields of regenerative medicine and cancer. Xintela specifically focuses on two areas in which there is a great need for new and better treatments: cartilage damage and brain tumors. Evy will share her experience on the importance of adopting new disruptive technology to be able to face our future health challenges.

Posted May 03, 2017 in: by linda

Comments are closed.

RSS